等待开盘 02-03 09:30:00 美东时间
-0.590
-2.00%
今日重点评级关注:瑞穗:维持Syndax制药"跑赢大市"评级,目标价从410美元升至600美元;HC Wainwright & Co.:维持60 Degrees Pharmaceuticals, Inc."买入"评级,目标价从6美元升至24美元
01-28 10:59
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Citigroup analyst Vikram Bagri maintains Delek US Hldgs (NYSE:DK) with a Neutral and lowers the price target from $37 to $33.
01-27 00:02
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04
JP Morgan analyst Zach Parham maintains Delek US Hldgs (NYSE:DK) with a Neutral and lowers the price target from $42 to $38.
01-16 03:12
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Piper Sandler analyst Ryan Todd maintains Delek US Hldgs (NYSE:DK) with a Neutral and lowers the price target from $47 to $40.
01-08 22:59
The most oversold stocks in the energy sector presents an opportunity to buy in...
01-02 19:05
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
Mizuho analyst Nitin Kumar maintains Delek US Hldgs (NYSE:DK) with a Outperform and raises the price target from $45 to $51.
2025-12-12 20:49